HRAS and colorectal carcinoma: We also notice that despite the low mutation rates of HRAS (0.3%) and NRAS (4.8%) in CRC overall, AWMC with signet ring cell component has more frequent HRAS and NRAS mutations than AWMC without signet ring cell component.